Analyst Predicts $20bn COVID Vaccines Market In 2021
Pfizer Expected To Take Early Lead
Analysts have taken a first stab at predicting the size of the COVID-19 vaccine market – in which Pfizer and Moderna are likely to start strong, but could give way to other big players.
You may also be interested in...
Initial results from the study are expected in early December 2020, which would allow the start of a Phase III trial before the end of the year.
Investors were spooked by mixed results from Alector’s lead candidate but the company’s CEO hit out at ‘hype’ around the biomarker
The UK company has raised its forecasts for 2021 after a better-than-expected Q2, even though Vaxzevria remains a very mixed blessing.